20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
GeneDx Holdings Corp. (WGS) operates in the DIAGNOSTICS & RESEARCH industry and is headquartered in Stamford, United States with about 1,300 employees. Its market capitalization is roughly $3 billion. In the fiscal year ended 2025-12-31, WGS reported $428M in revenue and ($21M) in net income.
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services.
Interactive charts & full statements → Open the WGS valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $454M | $428M | $305M | $203M | $235M | $212M | $179M | $196M |
| Gross Profit | $310M | $298M | $194M | $90M | ($27M) | ($17M) | $4M | $83M |
| Gross Margin % | 68.2% | 69.7% | 63.6% | 44.4% | -11.4% | -7.8% | 2.2% | 42.2% |
| Operating Income (EBIT) | ($61M) | ($12M) | ($23M) | ($181M) | ($668M) | ($446M) | ($242M) | ($30M) |
| Operating Margin % | -13.3% | -2.8% | -7.6% | -89.1% | -284.5% | -210.2% | -134.9% | -15.5% |
| Net Income | ($106M) | ($21M) | ($52M) | ($176M) | ($549M) | ($245M) | ($241M) | ($30M) |
| Net Margin % | -23.4% | -4.9% | -17.1% | -86.8% | -233.9% | -115.6% | -134.6% | -15.1% |
| EBITDA | ($76M) | $7M | ($28M) | ($136M) | ($398M) | ($221M) | ($227M) | ($23M) |
| Earnings Per Share (EPS) | $-3.68 | $-0.78 | $-1.94 | $-7.23 | $-53.63 | $-74.93 | $-42.89 | $-5.28 |
| Shares Outstanding (M) | 30M | 27M | 27M | 24M | 10M | 3M | 6M | 6M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $114M | $102M | $121M | $117M | $103M | $87M | $96M | $77M |
| Gross Profit | $78M | $68M | $79M | $85M | $71M | $58M | $66M | $48M |
| Gross Margin % | 68.4% | 66.7% | 65.2% | 72.4% | 69.0% | 67.1% | 69.2% | 62.2% |
| Operating Income (EBIT) | ($17M) | ($26M) | ($14M) | ($3M) | $9M | ($5M) | $9M | ($8M) |
| Operating Margin % | -15.2% | -25.6% | -11.3% | -2.8% | 8.7% | -5.2% | 9.2% | -10.1% |
| Net Income | ($18M) | ($63M) | ($18M) | ($8M) | $11M | ($7M) | $5M | ($8M) |
| Net Margin % | -15.5% | -61.9% | -14.6% | -6.5% | 10.5% | -7.5% | 5.7% | -10.8% |
| EBITDA | ($10M) | ($55M) | ($11M) | $0M | $18M | $0M | $12M | ($2M) |
| Earnings Per Share (EPS) | $-0.60 | $-2.16 | $-0.66 | $-0.27 | $0.36 | $-0.23 | $0.20 | $-0.31 |
| Shares Outstanding (M) | 30M | 29M | 27M | 29M | 30M | 28M | 27M | 27M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | ($49M) | $33M | ($28M) | ($180M) | ($319M) | ($190M) | ($93M) | ($19M) |
| Capital Expenditures (CapEx) | $27M | $19M | $5M | $6M | $14M | $21M | $32M | $15M |
| Free Cash Flow (FCF) | ($76M) | $14M | ($34M) | ($186M) | ($333M) | ($211M) | ($125M) | ($34M) |
| FCF Margin % | -16.7% | 3.3% | -11.1% | -91.8% | -142.1% | -99.5% | -69.8% | -17.4% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | ($29M) | ($32M) | ($3M) | $16M | $10M | $10M | ($3M) | ($4M) |
| Capital Expenditures (CapEx) | $10M | $6M | $4M | $6M | $2M | $6M | $3M | $1M |
| Free Cash Flow (FCF) | ($39M) | ($39M) | ($7M) | $10M | $8M | $4M | ($6M) | ($5M) |
| FCF Margin % | -34.2% | -38.0% | -6.2% | 8.2% | 7.8% | 4.7% | -6.5% | -6.6% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $481M | $570M | $419M | $419M | $545M | $554M | $252M | — |
| Cash & Cash Equivalents | $60M | $105M | $85M | $100M | $137M | $401M | $108M | — |
| Total Liabilities | $237M | $262M | $174M | $191M | $292M | $166M | $247M | — |
| Total Debt (Short + Long-Term) | $103M | $57M | $55M | $57M | $17M | $14M | $22M | $0M |
| Total Shareholders' Equity | $244M | $308M | $245M | $228M | $254M | $388M | $4M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive WGS viewer.
About TickerBase · Data methodology & sources · Privacy · Terms